el documento en el formato PDF
el documento en el formato PDF
el documento en el formato PDF
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Kod Bari Kodi ATC Emertimi Xh<strong>en</strong>erik Forma Emri Tregtar Firma Çmimi Ref. Çmimi Pac. Rimbursimi Kufizimet<br />
366/163 C09CA04 Irbersartan 150mg f.c.tabl. Irda 150 NOBEL ILAÇ<br />
SANOFI PHARMA,<br />
BRISTOL MYERS<br />
90.4 45.2 45.2<br />
366/198 C09CA04 Irbersartan 150mg tabl. Aprov<strong>el</strong><br />
SQUIBB 98.1 52.9 45.2<br />
367/163 C09CA04 Irbersartan 300mg f.c.tabl. Irda 300 NOBEL ILAÇ<br />
SANOFI PHARMA,<br />
BRISTOL MYERS<br />
112.1 56.1 56.0<br />
367/198 C09CA04 Irbersartan 300mg tabl. Aprov<strong>el</strong><br />
SQUIBB 119.1 63.1 56.0<br />
401/16 C09CA08 Olmesartan 10 mg f.c.tabl. M<strong>en</strong>artan BERLIN - CHEMIE 104.5 52.2 52.3<br />
402/16 C09CA08 Olmesartan 20 mg f.c.tabl. M<strong>en</strong>artan BERLIN - CHEMIE 124.9 62.4 62.5<br />
403/16 C09CA08 Olmesartan 40mg f.c.tabl. M<strong>en</strong>artan BERLIN - CHEMIE 154.1 77.1 77.0<br />
389/73<br />
Valsartan + Hydrochlortiazide<br />
C09DA03 80+12.5mg<br />
Valsartan + Hydrochlortiazide<br />
f.c.tabl. Valsacombi KRKA 98.1 49.1 49.0<br />
389/92 C09DA03 (80+12.5)mg f.c.tabl. Co-Diovan NOVARTIS 121.4 72.4 49.0<br />
414/73<br />
Valsartan +Hydrochlorthiazide<br />
C09DA03 (160+12.5)mg<br />
Valsartan +Hydrochlorthiazide<br />
f.c.tabl. Valsacombi KRKA 136.6 68.3 68.3<br />
414/92 C09DA03 (160+12.5)mg tabl. Co-Diovan NOVARTIS 168.1 99.8 68.3<br />
390/73<br />
Valsartan+Hydrochlortiazide<br />
C09DA03 (160+25)mg<br />
Valsartan+Hydrochlortiazide<br />
f.c.tabl. Valsacombi KRKA 136.6 68.3 68.3<br />
390/92 C09DA03 (160+25)mg f.c.tabl. Co-Diovan NOVARTIS 168.1 99.8 68.3<br />
Sipas protokollit te ISKSH, kur ACE-inhibitoret e tjere<br />
nuk toleroh<strong>en</strong>. Me konsulte te kardiologut, nefrologut,<br />
<strong>en</strong>dokrinologut.Deri ne 30 tabl. ne muaj.<br />
Sipas protokollit te ISKSH, kur ACE-inhibitoret e tjere<br />
nuk toleroh<strong>en</strong>. Me konsulte te kardiologut, nefrologut,<br />
<strong>en</strong>dokrinologut.Deri ne 30 tabl. ne muaj.<br />
Sipas protokollit te ISKSH, kur ACE-inhibitoret e tjere<br />
nuk toleroh<strong>en</strong>. Me konsulte te kardiologut, nefrologut,<br />
<strong>en</strong>dokrinologut.Deri ne 30 tabl. ne muaj.<br />
Sipas protokollit te ISKSH, kur ACE-inhibitoret e tjere<br />
nuk toleroh<strong>en</strong>. Me konsulte te kardiologut, nefrologut,<br />
<strong>en</strong>dokrinologut.Deri ne 30 tabl. ne muaj.<br />
Sipas protokollit te ISKSH, kur ACE-inhibitoret e tjere<br />
nuk toleroh<strong>en</strong>. Me konsulte te kardiologut, nefrologut,<br />
<strong>en</strong>dokrinologut.Deri ne 30 tabl. ne muaj.<br />
Sipas protokollit te ISKSH, kur ACE-inhibitoret e tjere<br />
nuk toleroh<strong>en</strong>. Me konsulte te kardiologut, nefrologut,<br />
<strong>en</strong>dokrinologut.Deri ne 30 tabl. ne muaj.<br />
Sipas protokollit te ISKSH, kur ACE-inhibitoret e tjere<br />
nuk toleroh<strong>en</strong>. Me konsulte te kardiologut, nefrologut,<br />
<strong>en</strong>dokrinologut.Deri ne 30 tabl. ne muaj.<br />
Sipas protokollit te ISKSH, kur ACE-inhibitoret e tjere<br />
nuk toleroh<strong>en</strong>. Me konsulte te kardiologut, nefrologut,<br />
<strong>en</strong>dokrinologut.Deri ne 30 tabl. ne muaj.